AGX NYSE Construction - Special Trade Contractors Financials FY2017βFY2026
Argan Inc had $945M of revenue in fiscal 2026, up 8.1% on the year before. Over five years, revenue changed +19.2% a year on average.
Last close Β· Oct 23, 2026
$331.03
0.2%Hi! I read Argan Incβs latest annual report (fiscal 2026). Here is what stands out:
Good So-so Weak
Are sales growing?
+8.1%
Yes. Sales grew 8.1% last year.
Does it make a profit?
14.6%
Yes. It keeps 14.6% of every sale as profit.
Does profit turn into cash?
43.5%
Yes. 43.5% of sales ends up as free cash.
How healthy are the accounts?
5 / 8
Mixed. It passes 5 of 8 health tests.
How is the share priced?
26.2x
One share costs 26.2 times its yearly profit per share.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA Β· Argan Inc had $945M of revenue in fiscal 2026, up 8.1% on the year before. Over five years, revenue changed +19.2% a year on average. Its operating margin was 14.3%, up 4.2Β pts: of every 100 in sales, about 14 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Argan Inc made $138M of net profit in fiscal 2026. From fiscal 2017 to 2026, diluted EPS grew 9.0% a year.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was $411M in fiscal 2026, 43.5% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
KIRA Β· Argan Inc returned $34.2M to shareholders in fiscal 2026, 8% of free cash flow. The diluted share count rose 1.7%.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· In the last 12 months, insiders sold $147M of shares on the open market and bought none.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$147M
11 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | John Ronald Jeffrey Jr.Director | Sold | 5,716 | $579.64 | $3.3M | Form 4 |
| Jun 22, 2026 | William F Griffin JrDirector, Gemma, Non-Executive Chairman | Sold | 20,000 | $760.43 | $15.2M | Form 4 |
| Jun 18, 2026 | William F Griffin JrDirector, Gemma, Non-Executive Chairman | Sold | 30,000 | $725.85 | $21.8M | Form 4 |
| Jun 17, 2026 | Peter W GetsingerDirector | Sold | 2,000 | $699.00 | $1.4M | Form 4 |
| Jun 17, 2026 | Karen SweeneyDirector | Sold | 300 | $705.00 | $0.2M | Form 4 |
| Jun 17, 2026 | Joshua Scott BaugherChief Financial Officer | Sold | 760 | $733.30 | $0.6M | Form 4 |
| Jun 16, 2026 | Peter W GetsingerDirector | Sold | 4,728 | $708.65 | $3.4M | Form 4 |
| Jun 16, 2026 | David Hibbert WatsonPresident and CEO, Director | Sold | 1,880 | $707.35 | $1.3M | Form 4 |
| Jun 15, 2026 | Cynthia FlandersDirector | Sold | 2,596 | $666.31 | $1.7M | Form 4 |
| Jun 15, 2026 | David Hibbert WatsonPresident and CEO, Director | Sold | 9,993 | $651.22 | $6.5M | Form 4 |
| Jun 12, 2026 | William F Griffin JrDirector, Gemma, Non-Executive Chairman | Sold | 50,000 | $643.46 | $32.2M | Form 4 |
| Apr 29, 2026 | Alexander Lisa LarroqueDirector | Sold | 350 | $630.58 | $0.2M | Form 4 |
| Apr 29, 2026 | Peter W GetsingerDirector | Sold | 3,000 | $628.36 | $1.9M | Form 4 |
| Apr 28, 2026 | William F. LeimkuhlerDirector | Sold | 5,800 | $617.75 | $3.6M | Form 4 |
| Apr 27, 2026 | John Ronald Jeffrey Jr.Director | Sold | 2,698 | $664.84 | $1.8M | Form 4 |
| Apr 21, 2026 | Charles Edwin Collins IVChief Executive Officer, Gemma | Sold | 11,068 | $621.61 | $6.9M | Form 4 |
| Apr 21, 2026 | John Ronald Jeffrey Jr.Director | Sold | 3,636 | $615.40 | $2.2M | Form 4 |
| Apr 20, 2026 | Charles Edwin Collins IVChief Executive Officer, Gemma | Sold | 2,500 | $610.00 | $1.5M | Form 4 |
| Apr 17, 2026 | David Hibbert WatsonPresident and CEO, Director | Sold | 19,310 | $602.11 | $11.6M | Form 4 |
| Apr 16, 2026 | Joshua Scott BaugherChief Financial Officer | Sold | 600 | $605.60 | $0.4M | Form 4 |
| Apr 13, 2026 | William F. LeimkuhlerDirector | Sold | 8,444 | $598.49 | $5.1M | Form 4 |
| Apr 2, 2026 | Peter W GetsingerDirector | Sold | 2,581 | $552.73 | $1.4M | Form 4 |
| Mar 31, 2026 | John Ronald Jeffrey Jr.Director | Sold | 4,556 | $539.85 | $2.5M | Form 4 |
| Jan 27, 2026 | John Ronald Jeffrey Jr.Director | Sold | 5,000 | $360.78 | $1.8M | Form 4 |
| Jan 21, 2026 | Cynthia FlandersDirector | Sold | 19,000 | $386.70 | $7.3M | Form 4 |
| Jan 20, 2026 | John Ronald Jeffrey Jr.Director | Sold | 2,700 | $380.60 | $1.0M | Form 4 |
| Jan 16, 2026 | William F. LeimkuhlerDirector | Sold | 11,044 | $379.15 | $4.2M | Form 4 |
| Jan 13, 2026 | William F. LeimkuhlerDirector | Sold | 4,212 | $320.53 | $1.4M | Form 4 |
| Jan 12, 2026 | William F. LeimkuhlerDirector | Sold | 2,164 | $318.28 | $0.7M | Form 4 |
| Jan 8, 2026 | Peter W GetsingerDirector | Sold | 6,595 | $313.71 | $2.1M | Form 4 |
| Jan 7, 2026 | Peter W GetsingerDirector | Sold | 4,000 | $328.34 | $1.3M | Form 4 |
| Dec 23, 2025 | William F. LeimkuhlerDirector | Sold | 200 | $337.47 | $0.1M | Form 4 |
| Dec 10, 2025 | James W QuinnDirector | Sold | 1,000 | $328.04 | $0.3M | Form 4 |
| Oct 20, 2025 | Peter W GetsingerDirector | Sold | 6,493 | $294.39 | $1.9M | Form 4 |
| Oct 17, 2025 | Peter W GetsingerDirector | Sold | 2,000 | $292.00 | $0.6M | Form 4 |
| Oct 15, 2025 | Charles Edwin Collins IVChief Executive Officer, Gemma | Sold | 10,000 | $309.37 | $3.1M | Form 4 |
| Oct 13, 2025 | Charles Edwin Collins IVChief Executive Officer, Gemma | Sold | 10,000 | $292.09 | $2.9M | Form 4 |
| Oct 9, 2025 | David Hibbert WatsonPresident and CEO, Director | Sold | 5,000 | $276.48 | $1.4M | Form 4 |
| Oct 8, 2025 | Cynthia FlandersDirector | Sold | 15,000 | $271.96 | $4.1M | Form 4 |
| Oct 1, 2025 | Charles Edwin Collins IVChief Executive Officer, Gemma | Sold | 5,000 | $275.00 | $1.4M | Form 4 |
| Oct 1, 2025 | William F. LeimkuhlerDirector | Sold | 11,802 | $274.73 | $3.2M | Form 4 |
| Sep 30, 2025 | James W QuinnDirector | Sold | 13,444 | $269.12 | $3.6M | Form 4 |
| Sep 29, 2025 | John Ronald Jeffrey Jr.Director | Sold | 4,698 | $268.60 | $1.3M | Form 4 |
Can it carry its debts, and how well does it use its money?
Cash, debt and the ratios that show how comfortably Argan Inc can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $350M | $325M | $307M | $298M | $491M |
| Current ratio | 2.3x | 2.2x | 1.8x | 1.6x | 1.6x |
| Quick ratio | 2.3x | 2.2x | 1.8x | 1.6x | 1.6x |
| Total assets | $554M | $489M | $598M | $836M | $1.2B |
| Total liabilities | $228M | $209M | $307M | $484M | $724M |
| Shareholders' equity | $326M | $281M | $291M | $352M | $462M |
| Net debt (β = net cash) | β | β | β | β | β |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Argan Inc passes 5 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 4 / 8 | 3 / 8 | 6 / 8 | 6 / 8 | 3 / 8 | 5 / 8 | 6 / 8 | 5 / 8 |
| Accruals ratio | β29.3% | 24.4% | 32.2% | β20.0% | β27.9% | 1.7% | 12.1% | β15.5% | β11.5% | β27.4% |
| Altman Z'' | 5.24 | 8.28 | 11.91 | 6.66 | 5.30 | 6.52 | 6.54 | 5.32 | 4.98 | 4.88 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $675M | $893M | $482M | $239M | $392M | $509M | $455M | $573M | $874M | $945M |
| Provision for credit losses | β | β | β | $0.0M | $0.0M | $2.4M | $0.1M | β | β | β |
| Gross profit | $147M | $149M | $82.4M | β$6.8M | $62.1M | $99.7M | $86.4M | $80.8M | $141M | $194M |
| Operating income | $112M | $107M | $40.2M | β$55.8M | $23.0M | $44.5M | $41.7M | $36.5M | $88.2M | $135M |
| Pretax income | $115M | $113M | $47.2M | β$47.8M | $24.9M | $47.1M | $46.0M | $48.9M | $111M | $161M |
| Income tax | $37.1M | $40.3M | β$4.7M | β$7.1M | $1.1M | $11.4M | $11.3M | $16.6M | $25.7M | $22.7M |
| Net income | $70.3M | $72.0M | $52.0M | β$42.7M | $23.9M | $38.2M | $33.1M | $32.4M | $85.5M | $138M |
| Diluted EPS | $4.50 | $4.56 | $3.32 | β$2.73 | $1.51 | $2.40 | $2.33 | $2.39 | $6.15 | $9.74 |
| Diluted shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $259M | β$72.8M | β$112M | $53.6M | $176M | $28.4M | β$30.1M | $117M | $168M | $415M |
| Capital expenditure | $2.8M | $4.8M | $8.6M | $7.1M | $1.7M | $1.4M | $3.4M | $2.8M | $6.6M | $3.9M |
| Free cash flow | $256M | β$77.6M | β$121M | $46.5M | $174M | $27.0M | β$33.4M | $114M | $161M | $411M |
| Depreciation and amortization | $2.0M | $2.8M | $3.4M | $3.5M | $3.7M | $3.4M | $3.0M | $2.0M | $1.9M | $1.9M |
| Stock-based compensation | $2.3M | $4.7M | $1.6M | $2.1M | $2.9M | $3.5M | $4.0M | $4.5M | $4.5M | $7.9M |
| Share buybacks | β | β | β | β | β | $20.4M | $68.2M | $12.5M | $1.5M | $9.9M |
| Dividends paid | β | β | β | β | $47.0M | $15.7M | $14.0M | $14.7M | $18.3M | $24.3M |
| Dividends and buybacks | β | β | β | β | $47.0M | $36.0M | $82.2M | $27.1M | $19.8M | $34.2M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $167M | $122M | $164M | $167M | $367M | $350M | $325M | $307M | $298M | $491M |
| Current assets | $588M | $485M | $416M | $422M | $546M | $507M | $439M | $547M | $781M | $1.1B |
| Current liabilities | $351M | $183M | $81.3M | $144M | $276M | $223M | $203M | $302M | $480M | $711M |
| Property and equipment, net | $13.1M | $15.3M | $19.8M | $22.5M | $20.4M | $10.5M | $10.4M | $11.0M | $14.5M | $16.6M |
| Goodwill | $34.9M | $34.3M | $32.8M | $27.9M | $27.9M | $28.0M | $28.0M | $28.0M | $28.0M | $28.0M |
| Intangible assets | $8.2M | $7.1M | $6.1M | $5.0M | $4.1M | $3.3M | $2.6M | $2.2M | $1.8M | $1.5M |
| Total assets | $644M | $543M | $477M | $488M | $603M | $554M | $489M | $598M | $836M | $1.2B |
| Total liabilities | $352M | $185M | $82.3M | $147M | $280M | $228M | $209M | $307M | $484M | $724M |
| Shareholders' equity | $292M | $358M | $395M | $339M | $321M | $326M | $281M | $291M | $352M | $462M |
| Margins | ||||||||||
| Gross margin | 21.7% | 16.7% | 17.1% | β2.9% | 15.8% | 19.6% | 19.0% | 14.1% | 16.1% | 20.5% |
| Operating margin | 16.6% | 12.0% | 8.3% | β23.4% | 5.9% | 8.7% | 9.2% | 6.4% | 10.1% | 14.3% |
| EBITDA margin | 16.9% | 12.3% | 9.1% | β21.9% | 6.8% | 9.4% | 9.8% | 6.7% | 10.3% | 14.5% |
| Net margin | 10.4% | 8.1% | 10.8% | β17.9% | 6.1% | 7.5% | 7.3% | 5.6% | 9.8% | 14.6% |
| FCF margin | 38.0% | β8.7% | β25.1% | 19.5% | 44.4% | 5.3% | β7.3% | 19.9% | 18.4% | 43.5% |
| Returns | ||||||||||
| Return on capital employed | 38.2% | 29.8% | 10.2% | β16.3% | 7.1% | 13.5% | 14.5% | 12.3% | 24.7% | 28.4% |
| Return on equity | 24.1% | 22.2% | 13.8% | β11.6% | 7.2% | 11.8% | 10.9% | 11.3% | 26.6% | 33.8% |
| Return on assets | 10.9% | 12.1% | 10.2% | β8.9% | 4.4% | 6.6% | 6.3% | 5.9% | 11.9% | 13.6% |
| Return on tangible equity | 28.3% | 22.7% | 14.6% | β13.9% | 8.3% | 13.0% | 13.2% | 12.4% | 26.5% | 31.8% |
| Growth | ||||||||||
| Revenue growth | β | 32.3% | β46.0% | β50.4% | 64.1% | 29.9% | β10.7% | 26.0% | 52.5% | 8.1% |
| Net income growth | β | 2.4% | β27.7% | β182.0% | β | 60.3% | β13.5% | β2.2% | 164.1% | 61.2% |
| EPS growth | β | 1.3% | β27.2% | β182.2% | β | 58.9% | β2.9% | 2.6% | 157.3% | 58.4% |
| FCF growth | β | β130.3% | β | β | 274.8% | β84.5% | β223.9% | β | 41.1% | 155.2% |
| Share count change | β | 1.0% | β0.6% | β0.5% | 1.3% | 0.6% | β10.9% | β4.4% | 2.6% | 1.7% |
| Financial health | ||||||||||
| Current ratio | 1.7x | 2.6x | 5.1x | 2.9x | 2.0x | 2.3x | 2.2x | 1.8x | 1.6x | 1.6x |
| Quick ratio | 1.7x | 2.6x | 5.1x | 2.9x | 2.0x | 2.3x | 2.2x | 1.8x | 1.6x | 1.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.4% | 0.5% | 1.8% | 3.0% | 0.4% | 0.3% | 0.7% | 0.5% | 0.8% | 0.4% |
| Stock comp / revenue | 0.3% | 0.5% | 0.3% | 0.9% | 0.7% | 0.7% | 0.9% | 0.8% | 0.5% | 0.8% |
| Payouts / FCF | β | β | β | β | 27.0% | 133.5% | β | 23.8% | 12.3% | 8.3% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 4.0 | 3.0 | 6.0 | 6.0 | 3.0 | 5.0 | 6.0 | 5.0 |
| Altman Z'' | 5.2 | 8.3 | 11.9 | 6.7 | 5.3 | 6.5 | 6.5 | 5.3 | 5.0 | 4.9 |
| Accruals ratio | β29.3% | 24.4% | 32.2% | β20.0% | β27.9% | 1.7% | 12.1% | β15.5% | β11.5% | β27.4% |
Source: SEC EDGAR XBRL filings (CIK 0000100591). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
